20/02/2026 (Agence Europe) – In a press release issued on Friday 20 February, the European Commission announced a record investment of €225 million to finance the development of a new generation of influenza vaccines. This initiative aims to create solutions that protect citizens against a wider range of variants and that can be rapidly adapted in the event of a pandemic. This is the first time that the European Commission has used pre-marketing public procurement contracts to support...